Eintrag weiter verarbeiten
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism
Gespeichert in:
| Zeitschriftentitel: | Acta Obstetricia et Gynecologica Scandinavica |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Acta Obstetricia et Gynecologica Scandinavica, 66, 1987, 4, S. 327-332 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. |
|---|---|
| author |
Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. |
| spellingShingle |
Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. Acta Obstetricia et Gynecologica Scandinavica Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism Obstetrics and Gynecology General Medicine |
| author_sort |
bertolini, s. |
| spelling |
Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. 0001-6349 1600-0412 Wiley Obstetrics and Gynecology General Medicine http://dx.doi.org/10.3109/00016348709103647 <jats:p>Three oral contraceptive preparations were studied in 60 healthy women. This randomized, comparative, baseline controlled study was designed to investigate the effects of the preparations on plasma lipids and lipoproteins. The following formulations were studied: a monophasic preparation containing ethinylestradiol and desogestrel (M‐DSG) and two triphasic formulations containing ethinylestradiol and gestodene or levonorgestrel respectively (T‐GSD and T‐LNG). These preparations were studied for six treatment cycles. Total cholesterol and apoprotein B did not change in any group. Low density lipoprotein (LDL) cholesterol was significantly decreased in the groups of women treated with M‐DSG and T‐GSD respectively. No changes were observed in the T‐LNG group. With M‐DSG, significant increases were observed in high‐density lipoprotein (HDL) cholesterol and HDL<jats:sub>3</jats:sub> cholesterol, whilst HDL<jats:sub>2</jats:sub> cholesterol did not change. With both T‐GSD and T‐LNG, no changes were observed in HDL cholesterol, whilst a significant increase in HDL<jats:sub>3</jats:sub> cholesterol together with a trend to decrease in HDL<jats:sub>2</jats:sub> cholesterol were observed. Apolipoprotein AI increased with the following ranking M‐DSG > T‐GSD > T‐LNG. The LDL/HDL cholesterol ratio significantly decreased with both M‐DSG and T‐GSD. In the T‐LNG group there was no change in this ratio. Triglycerides increased to the same extent in all treatment groups. As far as concerns the risk of arterial diseases, these three oral contraceptive formulations mostly induced negligible and/or partly favorable changes in plasma lipids and lipoproteins; however, the lipoprotein pattern during M‐DSG treatment resulted better than during T‐GSD, and the latter turned out to be better than during T‐LNG.</jats:p> Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism Acta Obstetricia et Gynecologica Scandinavica |
| doi_str_mv |
10.3109/00016348709103647 |
| facet_avail |
Online |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzEwOS8wMDAxNjM0ODcwOTEwMzY0Nw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzEwOS8wMDAxNjM0ODcwOTEwMzY0Nw |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-Ch1 |
| imprint |
Wiley, 1987 |
| imprint_str_mv |
Wiley, 1987 |
| issn |
0001-6349 1600-0412 |
| issn_str_mv |
0001-6349 1600-0412 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
bertolini1987effectsofthreelowdoseoralcontraceptiveformulationsonlipidmetabolism |
| publishDateSort |
1987 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Acta Obstetricia et Gynecologica Scandinavica |
| source_id |
49 |
| title |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_unstemmed |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_full |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_fullStr |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_full_unstemmed |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_short |
Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_sort |
effects of three low‐dose oral contraceptive formulations on lipid metabolism |
| topic |
Obstetrics and Gynecology General Medicine |
| url |
http://dx.doi.org/10.3109/00016348709103647 |
| publishDate |
1987 |
| physical |
327-332 |
| description |
<jats:p>Three oral contraceptive preparations were studied in 60 healthy women. This randomized, comparative, baseline controlled study was designed to investigate the effects of the preparations on plasma lipids and lipoproteins. The following formulations were studied: a monophasic preparation containing ethinylestradiol and desogestrel (M‐DSG) and two triphasic formulations containing ethinylestradiol and gestodene or levonorgestrel respectively (T‐GSD and T‐LNG). These preparations were studied for six treatment cycles. Total cholesterol and apoprotein B did not change in any group. Low density lipoprotein (LDL) cholesterol was significantly decreased in the groups of women treated with M‐DSG and T‐GSD respectively. No changes were observed in the T‐LNG group. With M‐DSG, significant increases were observed in high‐density lipoprotein (HDL) cholesterol and HDL<jats:sub>3</jats:sub> cholesterol, whilst HDL<jats:sub>2</jats:sub> cholesterol did not change. With both T‐GSD and T‐LNG, no changes were observed in HDL cholesterol, whilst a significant increase in HDL<jats:sub>3</jats:sub> cholesterol together with a trend to decrease in HDL<jats:sub>2</jats:sub> cholesterol were observed. Apolipoprotein AI increased with the following ranking M‐DSG > T‐GSD > T‐LNG. The LDL/HDL cholesterol ratio significantly decreased with both M‐DSG and T‐GSD. In the T‐LNG group there was no change in this ratio. Triglycerides increased to the same extent in all treatment groups. As far as concerns the risk of arterial diseases, these three oral contraceptive formulations mostly induced negligible and/or partly favorable changes in plasma lipids and lipoproteins; however, the lipoprotein pattern during M‐DSG treatment resulted better than during T‐GSD, and the latter turned out to be better than during T‐LNG.</jats:p> |
| container_issue |
4 |
| container_start_page |
327 |
| container_title |
Acta Obstetricia et Gynecologica Scandinavica |
| container_volume |
66 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792342546836357122 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:37:31.424Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effects+of+Three+Low%E2%80%90Dose+Oral+Contraceptive+Formulations+on+Lipid+Metabolism&rft.date=1987-01-01&genre=article&issn=1600-0412&volume=66&issue=4&spage=327&epage=332&pages=327-332&jtitle=Acta+Obstetricia+et+Gynecologica+Scandinavica&atitle=Effects+of+Three+Low%E2%80%90Dose+Oral+Contraceptive+Formulations+on+Lipid+Metabolism&aulast=De+Cecco&aufirst=L.&rft_id=info%3Adoi%2F10.3109%2F00016348709103647&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792342546836357122 |
| author | Bertolini, S., Elicio, N., Cordera, R., Gapitanio, G. L., Montagna, G., Croce, S., Saturnino, M., Balestreri, R., De Cecco, L. |
| author_facet | Bertolini, S., Elicio, N., Cordera, R., Gapitanio, G. L., Montagna, G., Croce, S., Saturnino, M., Balestreri, R., De Cecco, L., Bertolini, S., Elicio, N., Cordera, R., Gapitanio, G. L., Montagna, G., Croce, S., Saturnino, M., Balestreri, R., De Cecco, L. |
| author_sort | bertolini, s. |
| container_issue | 4 |
| container_start_page | 327 |
| container_title | Acta Obstetricia et Gynecologica Scandinavica |
| container_volume | 66 |
| description | <jats:p>Three oral contraceptive preparations were studied in 60 healthy women. This randomized, comparative, baseline controlled study was designed to investigate the effects of the preparations on plasma lipids and lipoproteins. The following formulations were studied: a monophasic preparation containing ethinylestradiol and desogestrel (M‐DSG) and two triphasic formulations containing ethinylestradiol and gestodene or levonorgestrel respectively (T‐GSD and T‐LNG). These preparations were studied for six treatment cycles. Total cholesterol and apoprotein B did not change in any group. Low density lipoprotein (LDL) cholesterol was significantly decreased in the groups of women treated with M‐DSG and T‐GSD respectively. No changes were observed in the T‐LNG group. With M‐DSG, significant increases were observed in high‐density lipoprotein (HDL) cholesterol and HDL<jats:sub>3</jats:sub> cholesterol, whilst HDL<jats:sub>2</jats:sub> cholesterol did not change. With both T‐GSD and T‐LNG, no changes were observed in HDL cholesterol, whilst a significant increase in HDL<jats:sub>3</jats:sub> cholesterol together with a trend to decrease in HDL<jats:sub>2</jats:sub> cholesterol were observed. Apolipoprotein AI increased with the following ranking M‐DSG > T‐GSD > T‐LNG. The LDL/HDL cholesterol ratio significantly decreased with both M‐DSG and T‐GSD. In the T‐LNG group there was no change in this ratio. Triglycerides increased to the same extent in all treatment groups. As far as concerns the risk of arterial diseases, these three oral contraceptive formulations mostly induced negligible and/or partly favorable changes in plasma lipids and lipoproteins; however, the lipoprotein pattern during M‐DSG treatment resulted better than during T‐GSD, and the latter turned out to be better than during T‐LNG.</jats:p> |
| doi_str_mv | 10.3109/00016348709103647 |
| facet_avail | Online |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzEwOS8wMDAxNjM0ODcwOTEwMzY0Nw |
| imprint | Wiley, 1987 |
| imprint_str_mv | Wiley, 1987 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1 |
| issn | 0001-6349, 1600-0412 |
| issn_str_mv | 0001-6349, 1600-0412 |
| language | English |
| last_indexed | 2024-03-01T16:37:31.424Z |
| match_str | bertolini1987effectsofthreelowdoseoralcontraceptiveformulationsonlipidmetabolism |
| mega_collection | Wiley (CrossRef) |
| physical | 327-332 |
| publishDate | 1987 |
| publishDateSort | 1987 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Acta Obstetricia et Gynecologica Scandinavica |
| source_id | 49 |
| spelling | Bertolini, S. Elicio, N. Cordera, R. Gapitanio, G. L. Montagna, G. Croce, S. Saturnino, M. Balestreri, R. De Cecco, L. 0001-6349 1600-0412 Wiley Obstetrics and Gynecology General Medicine http://dx.doi.org/10.3109/00016348709103647 <jats:p>Three oral contraceptive preparations were studied in 60 healthy women. This randomized, comparative, baseline controlled study was designed to investigate the effects of the preparations on plasma lipids and lipoproteins. The following formulations were studied: a monophasic preparation containing ethinylestradiol and desogestrel (M‐DSG) and two triphasic formulations containing ethinylestradiol and gestodene or levonorgestrel respectively (T‐GSD and T‐LNG). These preparations were studied for six treatment cycles. Total cholesterol and apoprotein B did not change in any group. Low density lipoprotein (LDL) cholesterol was significantly decreased in the groups of women treated with M‐DSG and T‐GSD respectively. No changes were observed in the T‐LNG group. With M‐DSG, significant increases were observed in high‐density lipoprotein (HDL) cholesterol and HDL<jats:sub>3</jats:sub> cholesterol, whilst HDL<jats:sub>2</jats:sub> cholesterol did not change. With both T‐GSD and T‐LNG, no changes were observed in HDL cholesterol, whilst a significant increase in HDL<jats:sub>3</jats:sub> cholesterol together with a trend to decrease in HDL<jats:sub>2</jats:sub> cholesterol were observed. Apolipoprotein AI increased with the following ranking M‐DSG > T‐GSD > T‐LNG. The LDL/HDL cholesterol ratio significantly decreased with both M‐DSG and T‐GSD. In the T‐LNG group there was no change in this ratio. Triglycerides increased to the same extent in all treatment groups. As far as concerns the risk of arterial diseases, these three oral contraceptive formulations mostly induced negligible and/or partly favorable changes in plasma lipids and lipoproteins; however, the lipoprotein pattern during M‐DSG treatment resulted better than during T‐GSD, and the latter turned out to be better than during T‐LNG.</jats:p> Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism Acta Obstetricia et Gynecologica Scandinavica |
| spellingShingle | Bertolini, S., Elicio, N., Cordera, R., Gapitanio, G. L., Montagna, G., Croce, S., Saturnino, M., Balestreri, R., De Cecco, L., Acta Obstetricia et Gynecologica Scandinavica, Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism, Obstetrics and Gynecology, General Medicine |
| title | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_full | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_fullStr | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_full_unstemmed | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_short | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| title_sort | effects of three low‐dose oral contraceptive formulations on lipid metabolism |
| title_unstemmed | Effects of Three Low‐Dose Oral Contraceptive Formulations on Lipid Metabolism |
| topic | Obstetrics and Gynecology, General Medicine |
| url | http://dx.doi.org/10.3109/00016348709103647 |